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HIGHLIGHTS 
 Diagnosis of HRV is extremely challenging due to genetic and serological variability 
within the HRV serotypes.  
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 We report a novel isothermal nucleic acid amplification method for the detection of 
HRV.  
 The method, reverse-transcription strand invasion–based amplification (RT-SIBA), 
detected HRV in clinical specimens with high analytical sensitivity and specificity 
(100%) 
 The method will facilitate prompt diagnosis of infection and thereby improving patient 
care. 
 
 
 
ABSTRACT 
 
Background: Rhinovirus (RV), a major cause of respiratory infection in humans, imposes an 
enormous economic burden due to the direct and indirect costs associated with the illness. 
Accurate and timely diagnosis is crucial for deciding the appropriate clinical approach and 
minimizing unnecessary prescription of antibiotics. Diagnosis of RV is extremely challenging 
due to genetic and serological variability among its numerous types and their similarity to 
enteroviruses. 
Objective: We sought to develop a rapid nucleic acid tests that can be used for the detection of 
Rhinovirus within both laboratory and near patient settings  
Study design: We developed and evaluated a novel isothermal nucleic acid amplification method 
called Reverse Transcription Strand Invasion-Based Amplification (RT-SIBA) to rapidly detect 
Rhinovirus from clinical specimens.  
Result: The method, RT-SIBA, detected RV in clinical specimens with high analytical 
sensitivity (96%) and specificity (100%). The time to positive result was significantly shorter 
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for the RV RT-SIBA assay than for a reference RV nucleic acid amplification method (RT-
qPCR). 
Conclusion: The rapid detection time of the RV SIBA assay, as well as its compatibility with 
portable instruments, will facilitate prompt diagnosis of infection and thereby improve patient 
care. 
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1. BACKGROUND 
 
 
Upper respiratory tract infection (URTI), which includes the common cold, is the most 
prevalent human illness. Rhinoviruses (RVs) are responsible for more than one-half of URTIs 
1, 2. RVs are positive-sense, single-stranded RNA viruses that belong to genus Enterovirus of 
family Picornaviridae. RVs comprise three species, Rhinovirus A, B, and C, and types within 
are commonly referred to by species letter and number (e.g. rhinovirus A2; RV-A2). To date, 
over 170 rhinovirus types have been identified, displaying high genetic and antigenic 
variability 2, 3. RV infection carries an enormous economic burden due to the direct and 
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indirect costs associated with the illness. In addition, to causing common cold, these viruses 
are the causative agents of many cases of severe pneumonia in the elderly and 
immunocompromised patients, as well as exacerbation of chronic obstructive pulmonary 
disease and asthma 1, 4, 5. Moreover, rhinovirus infection increases susceptibility to bacterial 
infection, e.g., by disrupting epithelial cell barrier function and promoting bacterial adhesion 
and internalization into epithelia 6, 7.  
 
Because respiratory infections can be caused by a variety of viral or bacterial pathogens, 
accurate and timely diagnosis is crucial for optimal management and treatment. Diagnosis of 
RVs is challenging due to genetic and antigenic variability among the types, as well as 
presentation of similar signs or symptoms in patients infected by bacterial or other viral 
respiratory pathogens. Furthermore, rhinoviruses grow slowly in cell culture, and RV-C is 
currently uncultivable 8, 9. Development of serology- and antibody-based detection methods 
has been hampered due to structural diversity of RV types  and slowness of the immune 
response to generate specific antibodies. Thus, real-time reverse transcription–polymerase 
chain reaction (RT-PCR) remains the only sensitive method for diagnosis of RVs 10, 11. RT-
PCR is often targeting the highly conserved 5′ noncoding region (NCR) of RV types (RV 
NCR). However, because the RV NCR region is highly similar between entero- and 
rhinoviruses, most RT-PCR methods cannot distinguish between rhinoviruses and other 
members of the Enterovirus genus 12. Consequently, commercial RV RT-PCR tests report 
combined results as Rhinovirus + Enterovirus. Furthermore, RT-qPCR requires thermal 
cyclers and skilled personnel, which are costly and require laboratory environments, limiting 
its use in field or point-of-care applications. Isothermal nucleic acid amplification methods 
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obviate the need for thermal cyclers because the reactions are performed at low and constant 
temperature.  
2. OBJECTIVE 
 
In this study, we developed an isothermal nucleic acid amplification method for the detection 
of RVs. This method, reverse-transcription strand invasion–based amplification (RT-SIBA), 
was previously shown to be useful for the diagnosis of infectious diseases 13-15. In RT-SIBA 
reactions, RNA is first reverse transcribed into cDNA, and then immediately amplified and 
detected under isothermal reaction conditions (Figure 1). The SIBA method relies on 
separation of the target duplex by a recombinase-coated invasion oligonucleotide (IO), 
allowing the primers to bind and DNA polymerase to extend the target sequence. The 
continuous strand separation and primer extension lead to exponential amplification of the 
target RNA under constant temperature. RT-SIBA detected RV in clinical samples with high 
analytical sensitivity and specificity comparable to diagnostic RT-qPCR methods. 
 
 
3. STUDY DESIGN 
 
3.1. Microbial strains and clinical specimens 
RV-A60 and RV-B17 were used as positive controls to establish the analytical sensitivity of 
the RT-SIBA assay. The 600-bp of the 5′ noncoding region (NCR) of RV-A60 and RV-B17 were 
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cloned into their respective pEX-A2 plasmid. (Eurofins, Germany) These plasmid were used as 
controls for the quantification of RV-A60 and RV-B17 viral RNA using qRT-PCR. A total of 19 
microbes (other than rhinoviruses) commonly found in respiratory specimens were used to 
determine the analytical specificity of the assay. A total of 26 respiratory clinical isolates (21 
rhinovirus, 3 coronavirus, and 2 enterovirus) were from collections of University of Turku 
(Turku, Finland). A total of 50 retrospective nasopharyngeal (NP) swab specimens were 
obtained from Helsinki University Hospital (Finland), 26 of which were positive for RV. The 
specimens were handled and tested anonymously. The ethical approvals as well as patients' 
consent were obtained to collect and use the specimens for development of diagnostic 
methods and applications. The clinical isolates and the specimens were used to evaluate 
clinical performance of both the RV SIBA and RV RT-PCR assays. All specimens were 
obtained and used in accordance with the bioethics policies of Helsinki University Hospital 
and University of Turku. 
3.2. Nucleic acid extraction 
RNA was extracted from viral strains, clinical isolates, and NPS specimens using the QIAamp 
Viral RNA Mini Kit (Qiagen, Germany). DNA was extracted from microbial strains using the 
QIAamp DNA Mini Kit (Qiagen). All extractions were conducted in accordance with the 
manufacturer’s protocols. 
3.3. RT-SIBA Rhino A and B assay design 
RV 5′ NCR sequences were retrieved from GenBank and aligned to identify conserved 
regions.  The RT-SIBA assay was designed to detect approximately 65 nucleotides in the 
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conserved 5′ NCR of the rhinovirus genome. The conserved 5′ NCR RV used for the RT-
SIBA assay was also selected to have sufficient mismatches with respect to enterovirus (EV) 
5′ NCR sequences allowing better differentiation of EV and RV. A set of primers and invasion 
oligonucleotides (IOs) were designed to amplify this target region. The RT-SIBA assay used 
one forward primer, one reverse primer, and one IO each to detect serotypes A and B. The 
serotype RT-SIBA oligonucleotides were approximately 95% identical to those for serotype 
C (rhinovirus C26). The 5’-end of the IO includes poly-cytosine nucleotides (poly-C) that are 
non-complementary to the target region (seeding region), which promotes optimal coating of 
the IO by the recombinase 16-18. Furthermore, the 3’-end of the IO are modified with 2’-O-
methyl RNA nucleotides in order to prevent IO DNA polymerase extension. The 
oligonucleotides used in this study were purchased from Integrated DNA Technologies 
(Leuven, Belgium). Primers and IOs were purified by reverse-phase HPLC and PAGE, 
respectively. The sequences of oligonucleotide used in this study are provided in Table 1. 
3.4. RV SIBA reaction  
RT-SIBA reactions were performed using the SIBA reagent kit (Orion Diagnostica Oy, Espoo, 
Finland) with the addition of 16 U of GoScript Reverse Transcriptase (Promega, Madison, 
USA). UvsX and Gp32 were used at 0.25 mg/ml and 0.4 mg/ml, respectively. The reactions 
were initiated with 10 mM magnesium acetate. Forward and reverse primers were used at 
final concentrations of 200 and 400 nM, respectively. SIBA reactions were optimized for rapid 
detection of types A and B by determining the optimal IO concentration and ratio of A and B 
IOs. Both IOs were tested at final concentrations of 100, 200, 300, and 400 nM. The optimal 
ratio of IOs was used for subsequent RV RT-SIBA experiments. 
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SIBA products were detected using SYBR Green 1 (dilution, 1:100,000; Thermo Fisher 
Scientific, Waltham, MA, USA). The standard SIBA reaction volume was 20 µl, including 2 µl 
of template. Reactions were incubated at 41°C for 60 min, and fluorescence readings were 
taken at 60 s intervals on a Bio-Rad CFX 96 (Bio-Rad Laboratories). A melting curve profile 
(40–95°C) was generated after each amplification reaction to further verify that the reaction 
products were specific. 
3.5. Rhinovirus RT-PCR  
The performance of the RT-SIBA assay was compared to highly sensitive RT-PCR assay for 
the detection of entero- and rhinoviruses 10. This assay uses entero+rhinovirus-specific 5’ 
NCR primers for RT-PCR followed by rhinovirus-specific LNA probes for specific detection of 
rhinoviruses. One-step RT-PCR reactions were performed using the Express One-Step 
SuperScript® qRT-PCR SuperMix Kit (Thermo Fisher Scientific). Primers and probes were 
used at 600 nM and 100 nM, respectively. Reaction products were detected on a CFX 95 
PCR instrument (Bio-Rad Laboratories, Finland). The following thermal cycling protocol was 
used: 50°C for 15 min (cDNA synthesis), 95°C for 2 min (reverse transcription and UDG 
inactivation), and 50 cycles of 95°C for 15 s and 60°C for 60 s (PCR amplification).  
 
4. RESULTS 
 
4.1. Optimization of the RV SIBA assay 
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The rhino RT-SIBA uses two sets of oligonucleotides (one for RV-A and one for RV-B), 
allowing the detection of the members of species Rhinovirus A and or Rhinovirus B within the 
same reaction tube. We reasoned that these sets of oligonucleotides, particularly the IOs, 
could compete among themselves, resulting in sub-optimal amplification conditions. 
Therefore, we sought to determine the optimal concentrations of RV-A and RV-B IO (RV-A-
IO and RV-B-IO) that would efficiently amplify both RV-A and and RV-B RNA in the same 
reaction tube. To this end, we conducted the RV RT-SIBA assay using 100–400 nM of each 
IO, and determined the effect of IO concentration on the detection time of RV A and B types.  
 
The amounts of time required to obtain a positive result from 1000 copies of RV-A and RV-B 
RNA per reaction are shown in Figure 2. A result was considered positive when the 
fluorescence signal exceeded the background signal. The amount of time to obtain a positive 
result for RV-A decreased (i.e., the amplification rate was faster) as the concentration of RV-
A-IO increased from 100 to 400 nM. However, an increase in the concentration of RV-A-IO 
also led to a dramatic increase in the time taken to detect RV-B virus (i.e., the amplification 
rate for RV-B RNA was slower). Similarly, increasing the RV-B-IO concentration from 100 to 
400 nM decreased the detection time for RV-B RNA but increased the detection time for RV-
A RNA. These results suggested that RV-A-IO and HRV-B-IO compete for reaction 
components. Based on optimization results, we performed subsequent experiments using RV-
A-IO and RV-B-IO at final concentrations of 200 and 300 nM, respectively. These 
concentrations allowed for optimal detection of RV-A and -B in the same reaction tube. 
4.2. Analytical sensitivity and specificity of the HRV SIBA and RT-PCR assay 
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The analytical sensitivities of the RV SIBA and RT-PCR assays were elucidated using 
quantified RNA extracted from rhinovirus A60 and B17. These experiments were performed 
in three independent replicates by adding serial dilutions of RNA (from 1 to 105 copies per 
reaction). Each RNA dilution was performed in triplicate, and the results are shown in Figure 
3 and Table 2. The RV SIBA assay detected as little as 10 copies of either rhinovirus A or B 
RNA. The RV SIBA assay detected 1000 copies of RV RNA in less than 30 min. In 
comparison, the lowest concentration of RV-A and RV-B RNA detected by RT-PCR was 1000 
and 100 copies, respectively. Furthermore, we performed Probit regression analysis to 
determine the limited of detection (LOD) for both RV RT-SIBA and RV RT-PCR, which is the 
concentration of RV RNA that were detected 95% of the time. Serial dilutions of quantified 
RV-A RNA and RV-B RNA from 104 to 100 copies were used. Each RNA dilution were 
performed using eight replicates. The LODs of RV RT-SIBA, for RV-A RNA and RV-B RNA 
were 31 and 15 copies per reaction, respectively. Meanwhile, The LODs of RV RT-PCR, for 
RV-A RNA and RV-B RNA were 662 and 17 copies per reaction, respectively. Thus, the RV 
RT-SIBA assay was more sensitive than the RV RT-PCR for detection of purified RV RNA 
particularly RV-A RNA. Furthermore, the time to positive results was significantly shorter for 
RV RT-SIBA than for RV RT-PCR, which took approximately 2 h. 
 
The analytical specificities of the RV RT-SIBA and RV-RT-PCR assays were determined by 
challenging the assays with DNA or RNA extracted from 19 microbial strains commonly found 
in respiratory specimens (Table 2). None of these 19 microbes were detected by either assay, 
indicating that both assays are highly specific for the detection of RV.   
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4.3. Evaluation of HRV SIBA and RT-PCR assays using clinical isolates and NPS specimens 
We compared the performance of RV SIBA and RT-PCR assays using RNA extracted from 
26 respiratory clinical isolates containing 21 rhinoviruses, 3 coronaviruses and 2 
enteroviruses (Table 3). Both the RV SIBA and RT-PCR assays only detected RV clinical 
isolates, and did not cross-react with coronaviruses or enteroviruses. The RV SIBA assay 
detected 20 of 21 RV isolates, whereas RT-PCR detected 21 of 21 HRV isolates.  
 
We further evaluated the performance of both the RV SIBA and RT-PCR assays using 50 
retrospective NPS specimens previously determined to be positive(N=26) or negative (N=24) 
for RV. The results are shown in Table 4. The RV SIBA assay detected 25 of 26 RV-positive 
specimens, whereas RV RT-PCR detected 26 of 26 RV-positive specimens. None of the 
negative RV NPS specimens was detected by the RV SIBA assay, whereas RV RT-PCR 
returned a positive result for one of the negative specimens. Based on comparisons with the 
previous results, the sensitivities and specificities of RV detection were 96% (95% CI: 81–
100%) and 100% (95% CI: 86–100%), respectively, for the RV SIBA assay, and 100% (95% 
CI: 87–100%) and 100% (95% CI: 96–100%), respectively, for the RV RT-PCR assay. This 
suggests that the RV SIBA assay is more specific, but slightly less sensitive, than RV RT-
PCR for the detection of NPS specimens. However, the RV SIBA assay had a significantly 
shorter time to positive result than the RV RT-PCR assay. 
 
5. DISCUSSION 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
12 
 
Diagnosis of RV is extremely challenging due to genetic and serological variability among its 
numerous types and their similarity to enteroviruses 8, 9. Nucleic acid amplification test 
(NAAT), i.e., RT-PCR, remains the most sensitive method for rhinovirus detection. These 
phenomena are responsible for inconsistent performance of most previously reported RV RT-
PCR assays 12. Furthermore, due to the requirement for thermal cycling instruments and 
skilled personnel, RT-PCR reactions are costly. Alternative NAAT techniques, such as 
isothermal nucleic acid amplification test (iNAAT), aim to overcome the problem of expensive 
instrumentation. 
 
In this study, we developed and evaluated an iNAAT, RT-SIBA, for rapid detection of RV. RT-
SIBA uses a reverse transcriptase, recombinase, and recombinase-coated oligonucleotide to 
catalyze separation of a specific target sequence within the RV genome. This setup enables 
target-specific RV primers to exponentially amplify the target sequence under isothermal 
conditions. This method was previously shown to be a rapid and highly sensitive technique 
for the detection of infectious diseases 13-15, 19, 20. The RV SIBA assay uses two sets of 
oligonucleotides, allowing for detection of RV-A and RV-B in a single reaction tube.  
 
We compared the performance of our RV SIBA assay with that of a previously published RV 
RT-PCR method 10. We found that the RV SIBA assay was more sensitive for the detection 
of low copy numbers of quantified RV RNA than the RV RT-PCR assay. In addition, we 
compared the performance of the RV SIBA and HRV RT-PCR assays using clinical isolates 
and NPS specimens. On the NPS specimens, the sensitivity and specificity of the RV SIBA 
assay were 96% and 100%, respectively, whereas those of the RV RT-PCR assay were 
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100% and 100%, respectively. Thus, RV SIBA assay exhibited slightly lower sensitivity than 
RV RT-PCR for the detection of RV from NPS specimens. The time to positive results was 
significantly shorter for RV SIBA than for the RV RT-PCR assay. A loop-mediated 
isothermal amplification method (LAMP) for the detection of RV had previously been 
reported21. Both SIBA and LAMP displayed similar performance with respect to the detection 
of RV from clinical specimens. However, SIBA displayed a faster time the LAMP particular 
for the detection of Rhinovirus B virus. 
 
The results of RV SIBA and RV RT-PCR were well correlated. However, to further evaluate 
the performance of both RV assays, it will be necessary to test a larger set of clinical 
specimens. Another limitation of our RV SIBA assay is that it was not tested with RV-C, mainly 
due to the unavailability of well-characterized RV-C types. The oligonucleotides used in our 
assay share approximately 95% identity with RV-C26, suggesting that the assay could also 
detect RV-C types. However, it may be necessary to include additional oligonucleotides to 
facilitate optimum detection of RV-C. Because the RV SIBA assay can be performed at low 
and constant temperature, the reactions can be performed using relatively small and 
inexpensive fluorescence readers. The shorter detection time of the RV SIBA assay, along 
with its compatibility with portable devices, will facilitate timely diagnosis of infection, thereby 
improving patient care and helping in avoiding unnecessary use of antibiotics.  
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Table 1. Oligonucleotides used for RV SIBA assay 
 
 
 
  
Name Sequence 5' --> 3' 
HRV-A F-primer TGCACTAGCTGCAGGGTTA 
HRV-A R-primer GTGTGCTCACTTTGAG 
HRV-B F-primer GTCTCAAGGCTCCAGGGTTT 
HRV-B R-primer GTGTGCTTAATTCTGAG 
HRV-A IO CCCCCCCCCCCCCCCAGGGTTAAGGTTAGCCACATTCAGGGGmCmCmGmGmAmGmGmAmCmUmCmA 
HRV-B IO CCCCCCCCCCCCCCCAGGGTTTAGGTTAGCCGCATTCAGGGGmCmCmGmGmAmGmGmAmCmUmCmA 
For invasion oligonucleotide (IO), bold sequences denote non-homologous seeding regions. mA, mC, mG, and mU denote 
2'-O-methyl RNA nucleotides. F, forward; R, reverse; HRV, Human Rhinovirus; SIBA, strand invasion–based amplification; 
HRV-A assay is designed to detect the sequence between position 421 and  483 within the genome of the  Human 
rhinovirus 60 strain ATCC VR-1473 ( GenBank: FJ445133.1); HRV-B assay is designed to detect the sequence between 
position 429 and  493 within the genome of the  Human rhinovirus 17 (GenBank: AF542419.1) 
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Table 2. Analytical sensitivity and average detection time of RT-SIBA vs. RT-PCR for the detection 
of RV 
 
RNA copy number/ RT-SIBA   RT-PCR 
reaction  Average amount of time taken  Average cycle threshold 
  to achieve positive results (min)  to achieve positive results (Ct)   
 
  HRV-A HRV-B  HRV-A HRV-B 
105  20 20  25 22 
104  23 24  29 26 
103  25 28  34 29 
102  28 31  ND 33 
101  40 34  ND ND 
0  ND ND  ND ND 
  
 
 
Table 3. List of microbes used for cross-reactivity testing 
 
Microbial strains HRV SIBA 
result 
HRV PCR 
result 
Rhinovirus A60  + + 
Rhinovirus B17 VR-1663 + + 
Enterovirus 71 ATCC VR-1432 - - 
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Streptococcus pyogenes NCTC 9994 - - 
Streptococcus dysgalactiae ATCC 12388 - - 
Streptococcus pneumoniae ATCC 6305 - - 
Streptococcus agalactiae ATCC 12386 - - 
Escherichia coli ATCC 25922 - - 
Klebsiella pneumoniae - - 
Neisseria sicca 29193 - - 
Neisseria meningitides BAA 335 - - 
Staphylococcus aureus ATCC 6538 - - 
Staphylococcus epidermidis 2954 - - 
Parainfluenza virus 1 ATCC  VR-94 - - 
Coronavirus ATCC-VR-740 - - 
Adenovirus 1 ATCC VR-1 - - 
Adenovirus 7 ATCC VR-7 - - 
Human respiratory syncytial virus A ATCC VR-1540 - - 
Human respiratory syncytial virus B ATCC VR-1400 - - 
Influenza A VR-1736 - - 
Influenza B VR-1813 - - 
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Table 4. Detection of RV clinical isolates using RV RT-SIBA and RT-PCR  
 
Microbial strains* HRV SIBA 
result 
HRV PCR 
result 
HRV-A1b + + 
HRV-A2 - + 
HRV-A12 + + 
HRV-A16 + + 
HRV-A20 + + 
HRV-A30 + + 
HRV-A34 + + 
HRV-A40 + + 
HRV-A44 + + 
HRV-A58 + + 
HRV-A66 + + 
HRV-A74 + + 
HRV-A78 + + 
HRV-A80 + + 
HRV-A85 + + 
HRV-A90 + + 
HRV-A95 + + 
HRV-B14 + + 
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HRV-B26 + + 
HRV-B52 + + 
HRV-B99 + + 
CV-B3 - - 
CV-B4 - - 
CV-A9 - - 
EV-11 - - 
EV-30 - - 
 
 
*HRV, human rhinovirus; CV, coronavirus; EV, enterovirus. 
Table 5. Clinical performance of RV SIBA assay vs. RT-PCR assay  
for detection of RV virus types  
 
 
 
 
 
HRV SIBA HRV PCR  
Positive Negative Positive Negative 
Positive 25 1 26 0 
Negative 0 24 1 23 
Total no. of samples 50 50 
Sensitivity (95% CI) 96% (81–100) 100% (87–100.0) 
Specificity (95% CI) 100 % (86–100) 100 % (86–100) AC
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Figure 1. Rhinovirus amplification by reverse-transcription strand invasion–based amplification (RT-
SIBA). 1) Rhinovirus RNA is reverse transcribed to cDNA by the reverse transcriptase enzyme 2) SIBA amplification requires an invasion 
oligonucleotide (IO) and two target-specific primers. 3) Single strand binding protein, Gp32 binds to oligonucleotides in order to reduce the 
formation of secondary structures. The recombinase protein, UvsX, coats the IO displacing the bound Gp32. 4) The recombinase-IO 
complex invades and separates the target duplex. 5) This allows target-specific primers to bind and extend the target via the action of a 
DNA polymerase. 6) This leads to the synthesis of two copies of the target duplex. 7) The continuous recombinase-mediated target duplex 
separation and DNA polymerase extension process leads to an exponential amplification under isothermal conditions. 
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Figure 2. Optimization of RV SIBA reaction conditions using different invasion oligonucleotide (IO) 
concentrations. (A) Amplification of 1000 copies of rhinovirus A60 RNA. (B)  
amplification of 1000 copies of rhinovirus B17 RNA; HRV-A-IO, rhinovirus A invasion  
oligonucleotide; RV-B-IO, rhinovirus B invasion oligonucleotide. 
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Figure 3. Sensitivity of RV SIBA assay for detection of rhinoviruses (RVs). (A)  
Rhinovirus A60 RNA. (B) rhinovirus B17 RNA; NTC, no template control. 
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